Table 2.
Intraocular pressure at baseline and at various times after intravitreal injection of bevacizumab
| IOP (mmHg), range | Number (%)
|
|||
|---|---|---|---|---|
| Baseline | 5 minutes after injection | 10 minutes after injection | 30 minutes after injection | |
| 0–19 | 49 (94.23) | 5 (9.61) | 16 (30.8) | 41 (78.8) |
| 20–24 | 2 (3.84) | 8 (15.38) | 11 (21.2) | 9 (17.3) |
| 25–29 | 1 (1.92) | 6 (11.53) | 10 (19.2) | 1 (1.92) |
| 30–34 | – | 9 (17.3) | 6 (11.53) | – |
| 35–39 | – | 7 (13.46) | 3 (5.8) | – |
| 40–44 | – | 6 (11.53) | 4 (7.69) | – |
| 45–49 | – | 6 (11.53) | – | 1 (1.92) |
| 50–59 | – | 4 (7.69) | 1 (1.92) | – |
| 60–69 | – | 1 (1.92) | 1 (1.92) | – |
| Mean IOP | 14.1 mmHg | 36.1 mmHg | 25.7 mmHg | 15.5 mmHg |
| 95% CI | 13.4–14.7 | 33.5–38.6 | 23.8–27.5 | 12.4–16.51 |
| P-value | <0.0005 | <0.02 | ||
Abbreviations: CI, confidence interval; IOP, intraocular pressure.